Oculis Appoints Dr. Frédéric Pilotaz as VP of Technology & Pharmaceutical Sciences

...

21 April, 2020

Oculis Appoints Marcia de Souza Lima, M.D., as Chief Medical Officer

03 March, 2020

Phase 2 Study Results of OCS-01: A Potential Topical Therapeutic for DME

10 February, 2020

Oculis Announces Upcoming Presentation of Phase 2 Data of OCS-01 in DME

22 January, 2020

Oculis Announces Dosing of First Patient in Randomized Phase 2b (SKYGGN) Trial

07 October, 2019

Oculis Announces Appointment of Leading Specialists to Scientific Advisory Board

17 September, 2019

Why a pharma investor quit his day job to follow a vision (Guest interview)

16 May, 2019

Oculis Expands Portfolio with a Novel Phase II-stage Anti-TNF alpha Antibody Fragment

04 January, 2019

Oculis Raises CHF15.5 million in an Extension of its Series B Financing Round

04 January, 2019

Oculis Strengthens its Global Clinical and Business Development Capabilities

20 November, 2018